DCM
BSX icon

Delpha Capital Management’s Boston Scientific BSX Stock Holding History

Delpha Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,434
Closed -$135K – 272
2017
Q4 		$135K Buy
+5,434
New +$150K 0.15% 97

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Delpha Capital Management's BSX Position: Q1 2018 in Review

Delpha Capital Management sold out of Boston Scientific (BSX) in Q1 2018, closing a stake of 5,434 shares — an estimated $135K sold.

Delpha Capital Management first reported a position in BSX in Q4 2017 and held it in 1 quarter. The position peaked at $135K in Q4 2017. 634 funds tracked by Wall St. Rank hold BSX as of Q1 2018.

  • Delpha Capital Management reported no remaining Boston Scientific position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 5,434 Boston Scientific shares in Q1 2018, an estimated $135K.
  • Delpha Capital Management first reported a position in Boston Scientific in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Boston Scientific position peaked at $135K in Q4 2017.
  • 634 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.